These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33603024)

  • 1. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis.
    Lind A; Marzinotto I; Brigatti C; Ramelius A; Piemonti L; Lampasona V
    Sci Rep; 2021 Feb; 11(1):4063. PubMed ID: 33603024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.
    Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å
    Viral Immunol; 2017 Oct; 30(8):590-600. PubMed ID: 28796576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
    Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
    J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.
    Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T
    PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling.
    Sadam H; Pihlak A; Kivil A; Pihelgas S; Jaago M; Adler P; Vilo J; Vapalahti O; Neuman T; Lindholm D; Partinen M; Vaheri A; Palm K
    EBioMedicine; 2018 Mar; 29():47-59. PubMed ID: 29449194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1.
    Vuorela A; Freitag TL; Leskinen K; Pessa H; Härkönen T; Stracenski I; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Ilonen J; Knip M; Vaheri A; Partinen M; Saavalainen P; Meri S; Vaarala O
    Nat Commun; 2021 Apr; 12(1):2283. PubMed ID: 33863907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in Pandemrix
    Wallenius M; Lind A; Akel O; Karlsson E; Svensson M; Arvidsson E; Ramelius A; Törn C; Palm L; Lernmark Å; Elding Larsson H
    Autoimmunity; 2019 Jun; 52(4):185-191. PubMed ID: 31328572
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to influenza virus A/H1N1 hemagglutinin in Type 1 diabetes children diagnosed before, during and after the SWEDISH A(H1N1)pdm09 vaccination campaign 2009-2010.
    Svensson M; Ramelius A; Nilsson AL; Delli AJ; Elding Larsson H; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Örtqvist E; Lernmark Å;
    Scand J Immunol; 2014 Feb; 79(2):137-48. PubMed ID: 24313339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.
    Lind A; Akel O; Wallenius M; Ramelius A; Maziarz M; Zhao LP; Geraghty DE; Palm L; Lernmark Å; Larsson HE
    PLoS One; 2019; 14(10):e0222882. PubMed ID: 31577807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
    Melén K; Partinen M; Tynell J; Sillanpää M; Himanen SL; Saarenpää-Heikkilä O; Hublin C; Olsen P; Ilonen J; Nohynek H; Syrjänen R; Kilpi T; Vuorela A; Kirjavainen T; Vaarala O; Julkunen I
    PLoS One; 2013; 8(8):e68402. PubMed ID: 23950869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy.
    De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E
    Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for autoantibody targets in post-vaccination narcolepsy using proteome arrays.
    Lind A; Eriksson D; Akel O; Ramelius A; Palm L; Lernmark Å; Kämpe O; Elding Larsson H; Landegren N
    Scand J Immunol; 2020 Apr; 91(4):e12864. PubMed ID: 32056243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy type 1 patients have lower levels of effector memory CD4
    Viste R; Lie BA; Viken MK; Rootwelt T; Knudsen-Heier S; Kornum BR
    Sleep Med; 2021 Sep; 85():271-279. PubMed ID: 34388506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 2013 incidence peak in childhood narcolepsy: more than vaccination?
    Zhang Z; Gool JK; Fronczek R; Dauvilliers Y; Bassetti CLA; Mayer G; Plazzi G; Pizza F; Santamaria J; Partinen M; Overeem S; Peraita-Adrados R; da Silva AM; Sonka K; Del Rio-Villegas R; Heinzer R; Wierzbicka A; Young P; Högl B; Manconi M; Feketeova E; Mathis J; Paiva T; Canellas F; Lecendreux M; Baumann CR; Lammers GJ; Khatami R
    Sleep; 2021 Feb; 44(2):. PubMed ID: 32909046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their non-narcoleptic siblings.
    Viste R; Follin LF; Kornum BR; Lie BA; Viken MK; Thorsby PM; Rootwelt T; Christensen JAE; Knudsen-Heier S
    Sleep; 2023 Mar; 46(3):. PubMed ID: 36562330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.
    Khurana S; Hahn M; Coyle EM; King LR; Lin TL; Treanor J; Sant A; Golding H
    Nat Commun; 2019 Jul; 10(1):3338. PubMed ID: 31350391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.
    Price JV; Jarrell JA; Furman D; Kattah NH; Newell E; Dekker CL; Davis MM; Utz PJ
    PLoS One; 2013; 8(5):e64555. PubMed ID: 23734205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.